Related Experiment Video
Updated: May 24, 2026

A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance
Published on: March 19, 2020
Resistance to TRAIL and how to surmount it
Danijela Maksimovic-Ivanic1, Stanislava Stosic-Grujicic, Ferdinando Nicoletti
1Department of Immunology, Institute for Biological Research Sinisa Stankovic, Belgrade University, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia.
Abstract:
Development of resistance to TRAIL-induced toxicity is one of the strategies used from tumor cells to escape destruction from the immune system. This process may occur through aberrant expression of functional receptors, overexpression of decoy receptors on tumor cell membrane, or malfunctioning of downstream signals triggered by specific ligation of TRAIL. Numerous cytostatic, but also noncytostatic, drugs like protease inhibitors and NO-hybridized molecules have been shown to revert sensitivity of neoplastic cells to TRAIL by means of different mechanisms. This paper will review the possible routes of reconstitution of sensitivity to TRAIL-mediated immune response by specific modulation of different signals responsible for the development of resistance at both the membrane and the intracellular levels. Moreover, we will review and suggest novel strategies, aimed at resetting immune cell efficiency in cancer treatment.
Insights
Tumor cells resist TRAIL-induced toxicity through receptor changes or signaling issues. This review explores strategies to restore TRAIL sensitivity and enhance immune cell efficiency in cancer therapy.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Tumor cells develop resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-induced toxicity as a survival mechanism.
- Resistance pathways include altered receptor expression (functional or decoy) and intracellular signaling defects.
- This resistance hinders effective anti-cancer immune responses.
Purpose of the Study:
- To review mechanisms by which tumor cells evade TRAIL-mediated apoptosis.
- To explore therapeutic strategies for overcoming TRAIL resistance.
- To suggest novel approaches for enhancing immune cell efficacy in cancer treatment.
Main Methods:
- Literature review of studies on TRAIL resistance mechanisms in cancer.
- Analysis of drug-induced sensitization to TRAIL (cytostatic and noncytostatic agents).
- Examination of intracellular and membrane-level signaling pathways involved in TRAIL resistance.
Main Results:
- Various drugs, including protease inhibitors and NO-hybridized molecules, can restore TRAIL sensitivity.
- Reconstitution of sensitivity involves modulating specific membrane and intracellular signals.
- Understanding these pathways is crucial for developing effective combination therapies.
Conclusions:
- Targeting resistance mechanisms can re-sensitize tumors to TRAIL-induced apoptosis.
- Novel strategies can reset immune cell efficiency for improved cancer treatment outcomes.
- Combination therapies hold promise for overcoming TRAIL resistance and enhancing anti-cancer immunity.
Related Concept Videos
Rolling Resistance: Problem Solving
Resistance
Trial and Error and Algorithm
Adjusting a Traverse
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...
Treatment Resistant Cancers

